Biotech R&D
A recent ICON survey of over 130 biotech executives shows that 60% expected to increase R&D spending, while only 2% planned to reduce funding. While confident in their outlook with regards to investment milestones and product success, significantly, 32% of respondents cited clinical trials as one of the biggest challenges in bringing novel therapies to market.
Overlooked element
In the ongoing global discourse surrounding environmental sustainability, the focus has predominantly been on carbon, largely spurred by the Paris Agreement and heightened climate change concerns. Surprisingly, nitrogen, a crucial yet often overlooked element, has not attracted the attention it deserves.
Bridging the skills gap for tech-savvy staff
The manufacturing sector is responsible for producing goods for consumption around the globe. However, the industry is under threat. A November 2023 survey by Eurobarometer discovered that skills shortages are a serious problem for small and medium-sized enterprises across the EU.